Program is subject to changes.
Click here to view the week-at-a-glance.
Please note that events are taking place at a number of venues For easy reference, use this legend to help find your way:
V - Victoria Conference Centre
F - Fairmont Empress
There is no food or beverage permitted in the lecture theatre (all plenary sessions).
Dr. Roxana Geoffrion MD
North Vancouver BC
Dr Roxana Geoffrion is an associate professor at the University of British Columbia and has a clinical practice as a urogynecologist at the Centre for Pelvic Floor at St. Paul’s Hospital in Vancouver. Dr Geoffrion completed her medical degree at McGill University in 2001 and her residency in Obstetrics and Gynecology at the University of Ottawa in 2006. She then pursued subspecialty fellowship training in Female Pelvic Medicine and Reconstructive Surgery, as well as a Faculty Teaching Certificate at the University of Calgary. Dr Geoffrion is the director of the UBC Advanced Training Program in Female Pelvic Medicine and Reconstructive Surgery. She mentors various trainees and also her peers in the performance of minimally invasive pelvic floor surgeries. In addition, she has a strong research interest in competency-based surgical education and has initiated two randomized controlled trials for teaching and evaluation of surgical skills in gynecologic surgery. Her other research interests include patient education in the area of pelvic floor health and prevention of disease, as well as surgical outcomes and sexual health of women with pelvic floor disorders. She was awarded a CIHR grant (2016-2021) to study long-term outcomes of two different surgical approaches for pelvic organ prolapse repair.
I have a relationship with a for-profit and/or a not-for-profit organization to disclose:
- Direct financial payments including receipt of honoraria: Boston Scientific preceptor proctor for Capio and Obtryx devices
- Membership on advisory boards or speakers’ bureaus: Duchesnay advisory board
- Funded grants or clinical trials: CIHR clinical trial
I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).